Inger Sandlie

Director/Miembro de la Junta en

Radiumhospitalets Forskningsstiftelse

73 años

34 relaciones

Finance

Consumer Services

Health Technology

Perfil

Inger Sandlie is the founder of Nykode Therapeutics ASA, founded in 2006, and Nextera AS, founded in 2009.
At Nextera AS, she held the title of Scientific Advisor.
Currently, Dr. Sandlie holds the position of Director at Radiumhospitalets Forskningsstiftelse and the title of Professor at the University of Oslo.

Cargos activos de Inger Sandlie

Empresas	Cargo	Inicio
Radiumhospitalets Forskningsstiftelse Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Invests in companies from Nordic research institutions	Director/Miembro de la Junta	-
University of Oslo University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

Todos los cargos activos de Inger Sandlie

Antiguos cargos conocidos de Inger Sandlie.

Empresas	Cargo	Fin
NYKODE THERAPEUTICS	Fundador	-
Nextera AS Nextera AS Miscellaneous Commercial ServicesCommercial Services Provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer	Fundador	-

Ver el detalle de la experiencia de Inger Sandlie.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Inger Sandlie.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
Radiumhospitalets Forskningsstiftelse Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Invests in companies from Nordic research institutions	Finance
University of Oslo University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nykode Therapeutics ASA Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer	Health Technology
Nextera AS Nextera AS Miscellaneous Commercial ServicesCommercial Services Provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer	Commercial Services